Literature DB >> 2542938

Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I.

R M Lynn1, M A Bjornsti, P R Caron, J C Wang.   

Abstract

Extensive digestion of the covalent intermediate between DNA and Saccharomyces cerevisiae DNA topoisomerase I with trypsin yields a 7-amino acid peptide covalently linked to DNA. Direct sequencing of the DNA-linked peptide identifies Tyr-727 as the active site tyrosine that forms an O4-phosphotyrosine bond with DNA when the enzyme cleaves a DNA phosphodiester bond. Site-directed mutagenesis of the cloned yeast TOP1 gene encoding the enzyme confirms the essentiality of Tyr-727 for the relaxation of supercoiled DNA by the enzyme. From amino acid sequence homology, Tyr-771 and -773 are readily identified as the active site tyrosines of Schizosaccharomyces pombe and human DNA topoisomerase I, respectively. Sequence comparison and site-directed mutagenesis also implicate Tyr-274 of vaccinia virus DNA topoisomerase as the active site residue. There appears to be a 70-amino acid domain near the carboxyl terminus of eukaryotic DNA topoisomerase I and vaccinia topoisomerase, within which the active site tyrosine resides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542938      PMCID: PMC287177          DOI: 10.1073/pnas.86.10.3559

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Cloning and sequencing of Schizosaccharomyces pombe DNA topoisomerase I gene, and effect of gene disruption.

Authors:  T Uemura; K Morino; S Uzawa; K Shiozaki; M Yanagida
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

2.  Identification of a vaccinia virus gene encoding a type I DNA topoisomerase.

Authors:  S Shuman; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.

Authors:  H Zhang; J C Wang; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Monoclonal antibodies neutralizing mammalian DNA topoisomerase I activity.

Authors:  P Oddou; U Schmidt; R Knippers; A Richter
Journal:  Eur J Biochem       Date:  1988-11-15

5.  cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.

Authors:  P D'Arpa; P S Machlin; H Ratrie; N F Rothfield; D W Cleveland; W C Earnshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 6.  Inhibitors of DNA topoisomerases.

Authors:  K Drlica; R J Franco
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

7.  Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II.

Authors:  M F Christman; F S Dietrich; G R Fink
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

8.  DNA topoisomerase-targeting antitumor drugs can be studied in yeast.

Authors:  J Nitiss; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Supercoiling of intracellular DNA can occur in eukaryotic cells.

Authors:  G N Giaever; J C Wang
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

10.  Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli.

Authors:  S Shuman; M Golder; B Moss
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

View more
  34 in total

1.  Protein engineering and site-directed mutagenesis. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1990-10       Impact factor: 2.926

2.  Intramolecular synapsis of duplex DNA by vaccinia topoisomerase.

Authors:  S Shuman; D G Bear; J Sekiguchi
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

3.  DNA strand transfer reactions catalyzed by vaccinia topoisomerase: hydrolysis and glycerololysis of the covalent protein-DNA intermediate.

Authors:  B O Petersen; S Shuman
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

4.  Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; E M Kane; S G Morham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Authors:  H Tamura; C Kohchi; R Yamada; T Ikeda; O Koiwai; E Patterson; J D Keene; K Okada; E Kjeldsen; K Nishikawa
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

6.  Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; I R Kirsch
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

7.  Isolation and characterization of a gene encoding DNA topoisomerase I in Drosophila melanogaster.

Authors:  T S Hsieh; S D Brown; P Huang; J Fostel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

8.  Protein footprinting by the combined use of reversible and irreversible lysine modifications.

Authors:  R Hanai; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 9.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Type II diabetes increases mitochondrial DNA mutations in the left ventricle of the Goto-Kakizaki diabetic rat.

Authors:  S Hicks; N Labinskyy; B Piteo; D Laurent; J E Mathew; S A Gupte; J G Edwards
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.